Illinois Ventures is the venture capital arm of the University of Illinois System, founded in 2000. It invests in early-stage deep tech companies with ties to the University of Illinois across sectors including AI, biotech, agtech, quantum, and clean tech.
40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (40% of deals). Average disclosed round size is $22.5M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Elion Therapeutics | Series B | $81M | Jun 2024 |
 Revenew | Series B | $5M | Oct 2013 |
 Syntax Bio | Unknown | $14.4M | — |
 Natrion | Seed | $2M | — |
 Samara aerospace | Seed | $10M | — |
Top Co-Investors
Altos Ventures Management, Inc.1 shared
Deerfield1 shared
AMR Action Fund1 shared
Illumina Ventures1 shared
Sigma Capital1 shared
Portal Innovations1 shared
Astellas Venture Management1 shared
Mayo Clinic Ventures1 shared
Draper Associates1 shared
Civilization Ventures1 shared
LG Technology Ventures1 shared
Tamarack Global1 shared
TechNexus Venture Collaborative1 shared
Techstars1 shared
Balerion Space Ventures1 shared
MFV Partners1 shared
Access Venture Partners1 shared
Last updated: 7 September 2026